查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594416

发作性睡病治疗市场：按药物类别、发作性睡病类型、分销管道划分 - 全球预测 2025-2030

Narcolepsy Treatment Market by Drug Class (CNS Stimulants, Decongestants, Serotonin Reuptake Inhibitors), Narcolepsy Type (Narcolepsy Type 1, Narcolepsy Type 2), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年发作性睡病治疗市值为38.6亿美元，预计到2024年将达到43.8亿美元，复合年增长率为13.45%，到2030年将达到93.6亿美元。

发作性睡病的治疗包括多种治疗性介入，旨在控制这种慢性神经系统疾病的症状，其特征是白天过度嗜睡和突然的肌肉无力（猝倒）。有效的发作性睡病治疗的需要会影响患者的生活品质和生产力，需要改善睡眠调节和白天的警觉性。治疗主要集中于药物解决方案，如兴奋剂、抗忧郁症和羟丁酸钠，以及行为疗法和生活方式改变。发作性睡病治疗的最终用途范围涵盖医院、专科诊所和居家照护等医疗机构，并且越来越多地透过远端医疗服务获得。

主要市场统计
基准年[2023] 38.6亿美元
预测年份 [2024] 43.8亿美元
预测年份 [2030] 93.6亿美元
复合年增长率（%） 13.45%

影响市场的主要成长要素包括对发作性睡病的认识提高、诊断能力提高以及药物治疗的进步。睡眠障碍的日益普及以及全球对心理健康的日益关注正在扩大市场潜力。近年来，新型药物传输系统和个人化医疗方法出现了巨大的商机，特别是那些针对Orexin胜肽的药物，它们对于调节觉醒非常重要。公司可以透过投资研发、促进与学术机构的合作以及利用人工智慧进行药物发现来抓住这些机会。

然而，市场成长受到多种挑战的限制，包括高昂的治疗成本、对发作性睡病发病机制的了解不足以及药物核准的高监管障碍。此外，与目前药物相关的副作用可能会抑制患者的依从性和接受度。设计永续且具成本效益的治疗方法，尤其是副作用较少的治疗方法，可以缓解这些限制。扩大对遗传和分子因素的研究也可能导致新治疗标靶的发现。

总体而言，市场动态在独特的挑战中带来了动态的机会。透过专注于创新药物治疗、探索发作性睡病的神经生理学基础以及改善医疗保健的可及性，公司可以在这个不断发展的领域中占据有利地位。这项策略重点将促进更全面、更有效的治疗方法的发展。

市场动态：快速发展的发作性睡病治疗市场的关键市场洞察

供给和需求的动态交互作用正在改变发作性睡病治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 睡眠障碍发作性睡病患者增加
    • 提高消费者对发作性睡病治疗的认识
    • 政府增加发作性睡病治疗的核准
  • 市场限制因素
    • 发作性睡病治疗的副作用
  • 市场机会
    • 关于发作性睡病治疗的研究活动增加
    • 优惠报销政策的出现
  • 市场挑战
    • 医护人员短缺

波特的五力：驾驭发作性睡病治疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解发作性睡病治疗市场的外部影响

外部宏观环境因素在塑造发作性睡病治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解发作性睡病治疗市场的竞争格局

对发作性睡病治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵发作性睡病治疗市场供应商的绩效评估

FPNV定位矩阵是评估发作性睡病治疗市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製发作性睡病治疗市场的成功之路

发作性睡病治疗市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 睡眠障碍发作性睡病增加
      • 提高消费者对发作性睡病治疗的认识
      • 政府对嗜睡症药物的核准增加
    • 抑制因素
      • 发作性睡病治疗的副作用
    • 机会
      • 与发作性睡病治疗相关的研究活动增加
      • 优惠报销政策的出现
    • 任务
      • 医护人员短缺
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章发作性睡病治疗市场（依药物类别）

  • 中枢神经系统兴奋剂
  • 减充血剂
  • 血清素再回收抑制剂
  • 血管收缩剂

第七章发作性睡病治疗市场（依发作性睡病类型）

  • 发作性睡病 1 型
  • 发作性睡病2型

第八章发作性睡病治疗市场：按分销管道

  • 药局
  • 电子商务
  • 零售药房

第九章美洲发作性睡病治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区发作性睡病治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的发作性睡病治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Addrenex Pharmaceuticals, Inc.
  • Arena Pharmaceuticals, Inc.
  • Avadel Pharmaceuticals plc
  • Axsome Therapeutics, Inc.
  • GlaxoSmithKline PLC
  • Graymark Healthcare Inc.
  • Harmony Biosciences LLC
  • Jazz Pharmaceuticals plc
  • Johnson & Johnson Services Inc.
  • Ligand Pharmaceuticals
  • Midas Pharma GmbH
  • Novartis AG
  • Pfizer Inc.
  • Shire Plc
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-036C5CF3B447

The Narcolepsy Treatment Market was valued at USD 3.86 billion in 2023, expected to reach USD 4.38 billion in 2024, and is projected to grow at a CAGR of 13.45%, to USD 9.36 billion by 2030.

Narcolepsy treatment encompasses a range of therapeutic interventions aimed at managing symptoms of this chronic neurological disorder, characterized by excessive daytime sleepiness and sudden muscle weakness (cataplexy). The necessity for effective narcolepsy treatment is driven by its impact on patient quality of life and productivity, necessitating improved sleep regulation and daytime alertness. Treatment applications primarily focus on pharmacological solutions, including stimulants, antidepressants, and sodium oxybate, as well as behavioral therapies and lifestyle modifications. The end-use scope for narcolepsy treatments spans healthcare settings such as hospitals, specialty clinics, and home care, with increasing accessibility through telehealth services.

KEY MARKET STATISTICS
Base Year [2023] USD 3.86 billion
Estimated Year [2024] USD 4.38 billion
Forecast Year [2030] USD 9.36 billion
CAGR (%) 13.45%

Key growth factors influencing the market include rising awareness about narcolepsy, improved diagnostic capabilities, and ongoing advancements in pharmacotherapy. The increasing prevalence of sleep disorders and a broader, global focus on mental health are expanding market potential. In recent years, significant opportunities have emerged with novel drug delivery systems and personalized medicine approaches, particularly in targeting orexin neuropeptides, which are crucial in regulating wakefulness. Companies could seize these opportunities by investing in R&D, fostering collaborations with academic institutions, and leveraging artificial intelligence for drug discovery.

However, market growth is constrained by several challenges, including the high cost of treatment, limited understanding of narcolepsy's etiology, and stringent regulatory hurdles for drug approval. Furthermore, side effects associated with current medications can impede patient adherence and acceptance. Innovating sustainable, cost-effective treatment options, particularly those with fewer side effects, can mitigate these limitations. Extending research into genetic or molecular factors may also unlock new therapeutic targets.

Overall, the market for narcolepsy treatment presents dynamic opportunities amid its inherent challenges. By focusing on innovation in drug therapies, exploring the neurophysiological underpinnings of narcolepsy, and enhancing healthcare accessibility, companies can position themselves advantageously in this evolving landscape. This strategic focus can facilitate the development of more comprehensive and effective treatment modalities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Narcolepsy Treatment Market

The Narcolepsy Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of sleep disorder narcolepsy
    • Growing consumer awareness regarding narcolepsy treatment
    • Rising government approvals for narcolepsy therapeutics
  • Market Restraints
    • Adverse effects of the narcolepsy treatment
  • Market Opportunities
    • Rise in the research activities related to the narcolepsy treatment
    • Emergence of favorable reimbursement policies
  • Market Challenges
    • Shortage of medical professionals

Porter's Five Forces: A Strategic Tool for Navigating the Narcolepsy Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Narcolepsy Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Narcolepsy Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Narcolepsy Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Narcolepsy Treatment Market

A detailed market share analysis in the Narcolepsy Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Narcolepsy Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Narcolepsy Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Narcolepsy Treatment Market

A strategic analysis of the Narcolepsy Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Narcolepsy Treatment Market, highlighting leading vendors and their innovative profiles. These include Addrenex Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., Avadel Pharmaceuticals plc, Axsome Therapeutics, Inc., GlaxoSmithKline PLC, Graymark Healthcare Inc., Harmony Biosciences LLC, Jazz Pharmaceuticals plc, Johnson & Johnson Services Inc., Ligand Pharmaceuticals, Midas Pharma GmbH, Novartis AG, Pfizer Inc., Shire Plc, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Narcolepsy Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Class, market is studied across CNS Stimulants, Decongestants, Serotonin Reuptake Inhibitors, and Vasopressors.
  • Based on Narcolepsy Type, market is studied across Narcolepsy Type 1 and Narcolepsy Type 2.
  • Based on Distribution Channel, market is studied across Drug Stores, E-commerce, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of sleep disorder narcolepsy
      • 5.1.1.2. Growing consumer awareness regarding narcolepsy treatment
      • 5.1.1.3. Rising government approvals for narcolepsy therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects of the narcolepsy treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in the research activities related to the narcolepsy treatment
      • 5.1.3.2. Emergence of favorable reimbursement policies
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of medical professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Narcolepsy Treatment Market, by Drug Class

  • 6.1. Introduction
  • 6.2. CNS Stimulants
  • 6.3. Decongestants
  • 6.4. Serotonin Reuptake Inhibitors
  • 6.5. Vasopressors

7. Narcolepsy Treatment Market, by Narcolepsy Type

  • 7.1. Introduction
  • 7.2. Narcolepsy Type 1
  • 7.3. Narcolepsy Type 2

8. Narcolepsy Treatment Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. E-commerce
  • 8.4. Retail Pharmacies

9. Americas Narcolepsy Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Narcolepsy Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Narcolepsy Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Addrenex Pharmaceuticals, Inc.
  • 2. Arena Pharmaceuticals, Inc.
  • 3. Avadel Pharmaceuticals plc
  • 4. Axsome Therapeutics, Inc.
  • 5. GlaxoSmithKline PLC
  • 6. Graymark Healthcare Inc.
  • 7. Harmony Biosciences LLC
  • 8. Jazz Pharmaceuticals plc
  • 9. Johnson & Johnson Services Inc.
  • 10. Ligand Pharmaceuticals
  • 11. Midas Pharma GmbH
  • 12. Novartis AG
  • 13. Pfizer Inc.
  • 14. Shire Plc
  • 15. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. NARCOLEPSY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. NARCOLEPSY TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NARCOLEPSY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NARCOLEPSY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NARCOLEPSY TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY CNS STIMULANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DECONGESTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY VASOPRESSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. NARCOLEPSY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023